iShares Biotechnology ETF (IBB)
NasdaqGM: IBB
· Prix en temps réel · USD
216.96
+13.40 (6.58%)
À la clôture : Aug 19, 2026, 3:41 PM
218.34
+0.64%
Après-Bourse: 6:09 PM
iShares Biotechnology ETF (IBB) ETF Price, Holdings & Analysis
6.58% (1D)
| Bid | 185.09 |
| Capitalisation boursière | n/a |
| AUM | 9.21B |
| NAV | 201.85 |
| Bêta | 0.7 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 28.14 |
| Parts en circulation | 69.7M |
| Date de création | Feb 5, 2001 |
| Ask | 197.12 |
| Volume | 1,138,661 |
| Moy. Volume (20D) | 1,541,812 |
| Ouverture | 210.04 |
| Clôture précédente | 203.56 |
| Fourchette du jour | 209.77 - 215.22 |
| Intervalle de 52 semaines | 136.89 - 215.22 |
| Positions | n / A |
| Ratio de frais | 0.44% |
À propos de IBB
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Classe d’actifs Equity
Symbole boursier IBB
Date de création Feb 5, 2001
Fournisseur Ishares
Site web Page d’accueil du fonds
Échange NasdaqGM
10 principaux titres 46.10% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Amgen Inc | AMGN | 8.51% |
| Vertex Pharmaceutica... | VRTX | 7.93% |
| Gilead Sciences Inc | GILD | 7.21% |
| Regeneron Pharmaceut... | REGN | 6.13% |
| Argenx Se Adr | ARGX | 3.54% |
| Natera Inc | NTRA | 2.91% |
| Revolution Medicines... | RVMD | 2.85% |
| Illumina Inc | ILMN | 2.47% |
| Biogen Inc | BIIB | 2.37% |
| Alnylam Pharmaceutic... | ALNY | 2.18% |
Dividendes Rendement du dividende 0.19%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Jun 15, 2026 | $0.0240 | n / A |
| Mar 17, 2026 | $0.1220 | n / A |
| Dec 16, 2025 | $0.1830 | n / A |
| Sep 16, 2025 | $0.0830 | n / A |
| Mar 18, 2025 | $0.1210 | n / A |
Page 1 de 2